Loteprednol Etabonate; Tobramycin Patent Expiration
Loteprednol Etabonate; Tobramycin is Used for treating inflammatory ocular conditions when a corticosteroid is needed and there is a risk of bacterial infection. It was first introduced by Bausch And Lomb Inc
Loteprednol Etabonate; Tobramycin Patents
Given below is the list of patents protecting Loteprednol Etabonate; Tobramycin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zylet |
US5540930 (Pediatric) | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Apr 25, 2014
(Expired) | Bausch And Lomb |
| Zylet |
US5747061 (Pediatric) | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Apr 25, 2014
(Expired) | Bausch And Lomb |
| Zylet | US5540930 | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Oct 25, 2013
(Expired) | Bausch And Lomb |
| Zylet | US5747061 | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
Oct 25, 2013
(Expired) | Bausch And Lomb |
| Zylet |
US4996335 (Pediatric) | Soft steroids having anti-inflammatory activity |
Sep 09, 2012
(Expired) | Bausch And Lomb |
Loteprednol Etabonate; Tobramycin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List